Global Budesonide (BUD) Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Budesonide (BUD) market size was valued at US$ 8024.6 million in 2023. With growing demand in downstream market, the Budesonide (BUD) is forecast to a readjusted size of US$ 11910 million by 2030 with a CAGR of 5.8% during review period.
The research report highlights the growth potential of the global Budesonide (BUD) market. Budesonide (BUD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Budesonide (BUD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Budesonide (BUD) market.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
Key Features:
The report on Budesonide (BUD) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Budesonide (BUD) market. It may include historical data, market segmentation by Type (e.g., Nasal Spray, Inhaler), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Budesonide (BUD) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Budesonide (BUD) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Budesonide (BUD) industry. This include advancements in Budesonide (BUD) technology, Budesonide (BUD) new entrants, Budesonide (BUD) new investment, and other innovations that are shaping the future of Budesonide (BUD).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Budesonide (BUD) market. It includes factors influencing customer ' purchasing decisions, preferences for Budesonide (BUD) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Budesonide (BUD) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Budesonide (BUD) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Budesonide (BUD) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Budesonide (BUD) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Budesonide (BUD) market.
Market Segmentation:
Budesonide (BUD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Budesonide (BUD) market?
What factors are driving Budesonide (BUD) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Budesonide (BUD) market opportunities vary by end market size?
How does Budesonide (BUD) break out type, application?
According to our LPI (LP Information) latest study, the global Budesonide (BUD) market size was valued at US$ 8024.6 million in 2023. With growing demand in downstream market, the Budesonide (BUD) is forecast to a readjusted size of US$ 11910 million by 2030 with a CAGR of 5.8% during review period.
The research report highlights the growth potential of the global Budesonide (BUD) market. Budesonide (BUD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Budesonide (BUD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Budesonide (BUD) market.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
Key Features:
The report on Budesonide (BUD) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Budesonide (BUD) market. It may include historical data, market segmentation by Type (e.g., Nasal Spray, Inhaler), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Budesonide (BUD) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Budesonide (BUD) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Budesonide (BUD) industry. This include advancements in Budesonide (BUD) technology, Budesonide (BUD) new entrants, Budesonide (BUD) new investment, and other innovations that are shaping the future of Budesonide (BUD).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Budesonide (BUD) market. It includes factors influencing customer ' purchasing decisions, preferences for Budesonide (BUD) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Budesonide (BUD) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Budesonide (BUD) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Budesonide (BUD) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Budesonide (BUD) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Budesonide (BUD) market.
Market Segmentation:
Budesonide (BUD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Nasal Spray
- Inhaler
- Pill
- Respiratory Disease Treatment
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Cosmo Pharmaceuticals
- Teva
- Mylan
- Sandoz
- Dr. Falk Pharma
- Chiesi Farmaceutici
- Orion
- Cipla
- Synmosa Biopharma
- Lunan Better Pharmaceutical
- Shanghai Sine Promod Pharmaceutical
What is the 10-year outlook for the global Budesonide (BUD) market?
What factors are driving Budesonide (BUD) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Budesonide (BUD) market opportunities vary by end market size?
How does Budesonide (BUD) break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Budesonide (BUD) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Budesonide (BUD) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Budesonide (BUD) by Country/Region, 2019, 2023 & 2030
2.2 Budesonide (BUD) Segment by Type
2.2.1 Nasal Spray
2.2.2 Inhaler
2.2.3 Pill
2.3 Budesonide (BUD) Sales by Type
2.3.1 Global Budesonide (BUD) Sales Market Share by Type (2019-2024)
2.3.2 Global Budesonide (BUD) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Budesonide (BUD) Sale Price by Type (2019-2024)
2.4 Budesonide (BUD) Segment by Application
2.4.1 Respiratory Disease Treatment
2.4.2 Nose Disease Treatment
2.4.3 Inflammatory Bowel Disease Treatment
2.5 Budesonide (BUD) Sales by Application
2.5.1 Global Budesonide (BUD) Sale Market Share by Application (2019-2024)
2.5.2 Global Budesonide (BUD) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Budesonide (BUD) Sale Price by Application (2019-2024)
3 GLOBAL BUDESONIDE (BUD) BY COMPANY
3.1 Global Budesonide (BUD) Breakdown Data by Company
3.1.1 Global Budesonide (BUD) Annual Sales by Company (2019-2024)
3.1.2 Global Budesonide (BUD) Sales Market Share by Company (2019-2024)
3.2 Global Budesonide (BUD) Annual Revenue by Company (2019-2024)
3.2.1 Global Budesonide (BUD) Revenue by Company (2019-2024)
3.2.2 Global Budesonide (BUD) Revenue Market Share by Company (2019-2024)
3.3 Global Budesonide (BUD) Sale Price by Company
3.4 Key Manufacturers Budesonide (BUD) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Budesonide (BUD) Product Location Distribution
3.4.2 Players Budesonide (BUD) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BUDESONIDE (BUD) BY GEOGRAPHIC REGION
4.1 World Historic Budesonide (BUD) Market Size by Geographic Region (2019-2024)
4.1.1 Global Budesonide (BUD) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Budesonide (BUD) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Budesonide (BUD) Market Size by Country/Region (2019-2024)
4.2.1 Global Budesonide (BUD) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Budesonide (BUD) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Budesonide (BUD) Sales Growth
4.4 APAC Budesonide (BUD) Sales Growth
4.5 Europe Budesonide (BUD) Sales Growth
4.6 Middle East & Africa Budesonide (BUD) Sales Growth
5 AMERICAS
5.1 Americas Budesonide (BUD) Sales by Country
5.1.1 Americas Budesonide (BUD) Sales by Country (2019-2024)
5.1.2 Americas Budesonide (BUD) Revenue by Country (2019-2024)
5.2 Americas Budesonide (BUD) Sales by Type
5.3 Americas Budesonide (BUD) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Budesonide (BUD) Sales by Region
6.1.1 APAC Budesonide (BUD) Sales by Region (2019-2024)
6.1.2 APAC Budesonide (BUD) Revenue by Region (2019-2024)
6.2 APAC Budesonide (BUD) Sales by Type
6.3 APAC Budesonide (BUD) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Budesonide (BUD) by Country
7.1.1 Europe Budesonide (BUD) Sales by Country (2019-2024)
7.1.2 Europe Budesonide (BUD) Revenue by Country (2019-2024)
7.2 Europe Budesonide (BUD) Sales by Type
7.3 Europe Budesonide (BUD) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Budesonide (BUD) by Country
8.1.1 Middle East & Africa Budesonide (BUD) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Budesonide (BUD) Revenue by Country (2019-2024)
8.2 Middle East & Africa Budesonide (BUD) Sales by Type
8.3 Middle East & Africa Budesonide (BUD) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Budesonide (BUD)
10.3 Manufacturing Process Analysis of Budesonide (BUD)
10.4 Industry Chain Structure of Budesonide (BUD)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Budesonide (BUD) Distributors
11.3 Budesonide (BUD) Customer
12 WORLD FORECAST REVIEW FOR BUDESONIDE (BUD) BY GEOGRAPHIC REGION
12.1 Global Budesonide (BUD) Market Size Forecast by Region
12.1.1 Global Budesonide (BUD) Forecast by Region (2025-2030)
12.1.2 Global Budesonide (BUD) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Budesonide (BUD) Forecast by Type
12.7 Global Budesonide (BUD) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Budesonide (BUD) Product Portfolios and Specifications
13.1.3 AstraZeneca Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Cosmo Pharmaceuticals
13.2.1 Cosmo Pharmaceuticals Company Information
13.2.2 Cosmo Pharmaceuticals Budesonide (BUD) Product Portfolios and Specifications
13.2.3 Cosmo Pharmaceuticals Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Cosmo Pharmaceuticals Main Business Overview
13.2.5 Cosmo Pharmaceuticals Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Budesonide (BUD) Product Portfolios and Specifications
13.3.3 Teva Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Budesonide (BUD) Product Portfolios and Specifications
13.4.3 Mylan Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Sandoz
13.5.1 Sandoz Company Information
13.5.2 Sandoz Budesonide (BUD) Product Portfolios and Specifications
13.5.3 Sandoz Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sandoz Main Business Overview
13.5.5 Sandoz Latest Developments
13.6 Dr. Falk Pharma
13.6.1 Dr. Falk Pharma Company Information
13.6.2 Dr. Falk Pharma Budesonide (BUD) Product Portfolios and Specifications
13.6.3 Dr. Falk Pharma Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Dr. Falk Pharma Main Business Overview
13.6.5 Dr. Falk Pharma Latest Developments
13.7 Chiesi Farmaceutici
13.7.1 Chiesi Farmaceutici Company Information
13.7.2 Chiesi Farmaceutici Budesonide (BUD) Product Portfolios and Specifications
13.7.3 Chiesi Farmaceutici Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Chiesi Farmaceutici Main Business Overview
13.7.5 Chiesi Farmaceutici Latest Developments
13.8 Orion
13.8.1 Orion Company Information
13.8.2 Orion Budesonide (BUD) Product Portfolios and Specifications
13.8.3 Orion Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Orion Main Business Overview
13.8.5 Orion Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Budesonide (BUD) Product Portfolios and Specifications
13.9.3 Cipla Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 Synmosa Biopharma
13.10.1 Synmosa Biopharma Company Information
13.10.2 Synmosa Biopharma Budesonide (BUD) Product Portfolios and Specifications
13.10.3 Synmosa Biopharma Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Synmosa Biopharma Main Business Overview
13.10.5 Synmosa Biopharma Latest Developments
13.11 Lunan Better Pharmaceutical
13.11.1 Lunan Better Pharmaceutical Company Information
13.11.2 Lunan Better Pharmaceutical Budesonide (BUD) Product Portfolios and Specifications
13.11.3 Lunan Better Pharmaceutical Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Lunan Better Pharmaceutical Main Business Overview
13.11.5 Lunan Better Pharmaceutical Latest Developments
13.12 Shanghai Sine Promod Pharmaceutical
13.12.1 Shanghai Sine Promod Pharmaceutical Company Information
13.12.2 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Portfolios and Specifications
13.12.3 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Shanghai Sine Promod Pharmaceutical Main Business Overview
13.12.5 Shanghai Sine Promod Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Budesonide (BUD) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Budesonide (BUD) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Budesonide (BUD) by Country/Region, 2019, 2023 & 2030
2.2 Budesonide (BUD) Segment by Type
2.2.1 Nasal Spray
2.2.2 Inhaler
2.2.3 Pill
2.3 Budesonide (BUD) Sales by Type
2.3.1 Global Budesonide (BUD) Sales Market Share by Type (2019-2024)
2.3.2 Global Budesonide (BUD) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Budesonide (BUD) Sale Price by Type (2019-2024)
2.4 Budesonide (BUD) Segment by Application
2.4.1 Respiratory Disease Treatment
2.4.2 Nose Disease Treatment
2.4.3 Inflammatory Bowel Disease Treatment
2.5 Budesonide (BUD) Sales by Application
2.5.1 Global Budesonide (BUD) Sale Market Share by Application (2019-2024)
2.5.2 Global Budesonide (BUD) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Budesonide (BUD) Sale Price by Application (2019-2024)
3 GLOBAL BUDESONIDE (BUD) BY COMPANY
3.1 Global Budesonide (BUD) Breakdown Data by Company
3.1.1 Global Budesonide (BUD) Annual Sales by Company (2019-2024)
3.1.2 Global Budesonide (BUD) Sales Market Share by Company (2019-2024)
3.2 Global Budesonide (BUD) Annual Revenue by Company (2019-2024)
3.2.1 Global Budesonide (BUD) Revenue by Company (2019-2024)
3.2.2 Global Budesonide (BUD) Revenue Market Share by Company (2019-2024)
3.3 Global Budesonide (BUD) Sale Price by Company
3.4 Key Manufacturers Budesonide (BUD) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Budesonide (BUD) Product Location Distribution
3.4.2 Players Budesonide (BUD) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BUDESONIDE (BUD) BY GEOGRAPHIC REGION
4.1 World Historic Budesonide (BUD) Market Size by Geographic Region (2019-2024)
4.1.1 Global Budesonide (BUD) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Budesonide (BUD) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Budesonide (BUD) Market Size by Country/Region (2019-2024)
4.2.1 Global Budesonide (BUD) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Budesonide (BUD) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Budesonide (BUD) Sales Growth
4.4 APAC Budesonide (BUD) Sales Growth
4.5 Europe Budesonide (BUD) Sales Growth
4.6 Middle East & Africa Budesonide (BUD) Sales Growth
5 AMERICAS
5.1 Americas Budesonide (BUD) Sales by Country
5.1.1 Americas Budesonide (BUD) Sales by Country (2019-2024)
5.1.2 Americas Budesonide (BUD) Revenue by Country (2019-2024)
5.2 Americas Budesonide (BUD) Sales by Type
5.3 Americas Budesonide (BUD) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Budesonide (BUD) Sales by Region
6.1.1 APAC Budesonide (BUD) Sales by Region (2019-2024)
6.1.2 APAC Budesonide (BUD) Revenue by Region (2019-2024)
6.2 APAC Budesonide (BUD) Sales by Type
6.3 APAC Budesonide (BUD) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Budesonide (BUD) by Country
7.1.1 Europe Budesonide (BUD) Sales by Country (2019-2024)
7.1.2 Europe Budesonide (BUD) Revenue by Country (2019-2024)
7.2 Europe Budesonide (BUD) Sales by Type
7.3 Europe Budesonide (BUD) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Budesonide (BUD) by Country
8.1.1 Middle East & Africa Budesonide (BUD) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Budesonide (BUD) Revenue by Country (2019-2024)
8.2 Middle East & Africa Budesonide (BUD) Sales by Type
8.3 Middle East & Africa Budesonide (BUD) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Budesonide (BUD)
10.3 Manufacturing Process Analysis of Budesonide (BUD)
10.4 Industry Chain Structure of Budesonide (BUD)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Budesonide (BUD) Distributors
11.3 Budesonide (BUD) Customer
12 WORLD FORECAST REVIEW FOR BUDESONIDE (BUD) BY GEOGRAPHIC REGION
12.1 Global Budesonide (BUD) Market Size Forecast by Region
12.1.1 Global Budesonide (BUD) Forecast by Region (2025-2030)
12.1.2 Global Budesonide (BUD) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Budesonide (BUD) Forecast by Type
12.7 Global Budesonide (BUD) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Budesonide (BUD) Product Portfolios and Specifications
13.1.3 AstraZeneca Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Cosmo Pharmaceuticals
13.2.1 Cosmo Pharmaceuticals Company Information
13.2.2 Cosmo Pharmaceuticals Budesonide (BUD) Product Portfolios and Specifications
13.2.3 Cosmo Pharmaceuticals Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Cosmo Pharmaceuticals Main Business Overview
13.2.5 Cosmo Pharmaceuticals Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Budesonide (BUD) Product Portfolios and Specifications
13.3.3 Teva Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Budesonide (BUD) Product Portfolios and Specifications
13.4.3 Mylan Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Sandoz
13.5.1 Sandoz Company Information
13.5.2 Sandoz Budesonide (BUD) Product Portfolios and Specifications
13.5.3 Sandoz Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sandoz Main Business Overview
13.5.5 Sandoz Latest Developments
13.6 Dr. Falk Pharma
13.6.1 Dr. Falk Pharma Company Information
13.6.2 Dr. Falk Pharma Budesonide (BUD) Product Portfolios and Specifications
13.6.3 Dr. Falk Pharma Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Dr. Falk Pharma Main Business Overview
13.6.5 Dr. Falk Pharma Latest Developments
13.7 Chiesi Farmaceutici
13.7.1 Chiesi Farmaceutici Company Information
13.7.2 Chiesi Farmaceutici Budesonide (BUD) Product Portfolios and Specifications
13.7.3 Chiesi Farmaceutici Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Chiesi Farmaceutici Main Business Overview
13.7.5 Chiesi Farmaceutici Latest Developments
13.8 Orion
13.8.1 Orion Company Information
13.8.2 Orion Budesonide (BUD) Product Portfolios and Specifications
13.8.3 Orion Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Orion Main Business Overview
13.8.5 Orion Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Budesonide (BUD) Product Portfolios and Specifications
13.9.3 Cipla Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 Synmosa Biopharma
13.10.1 Synmosa Biopharma Company Information
13.10.2 Synmosa Biopharma Budesonide (BUD) Product Portfolios and Specifications
13.10.3 Synmosa Biopharma Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Synmosa Biopharma Main Business Overview
13.10.5 Synmosa Biopharma Latest Developments
13.11 Lunan Better Pharmaceutical
13.11.1 Lunan Better Pharmaceutical Company Information
13.11.2 Lunan Better Pharmaceutical Budesonide (BUD) Product Portfolios and Specifications
13.11.3 Lunan Better Pharmaceutical Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Lunan Better Pharmaceutical Main Business Overview
13.11.5 Lunan Better Pharmaceutical Latest Developments
13.12 Shanghai Sine Promod Pharmaceutical
13.12.1 Shanghai Sine Promod Pharmaceutical Company Information
13.12.2 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Portfolios and Specifications
13.12.3 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Shanghai Sine Promod Pharmaceutical Main Business Overview
13.12.5 Shanghai Sine Promod Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Budesonide (BUD) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Budesonide (BUD) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Nasal Spray
Table 4. Major Players of Inhaler
Table 5. Major Players of Pill
Table 6. Global Budesonide (BUD) Sales by Type (2019-2024) & (K MT)
Table 7. Global Budesonide (BUD) Sales Market Share by Type (2019-2024)
Table 8. Global Budesonide (BUD) Revenue by Type (2019-2024) & ($ million)
Table 9. Global Budesonide (BUD) Revenue Market Share by Type (2019-2024)
Table 10. Global Budesonide (BUD) Sale Price by Type (2019-2024) & (USD/MT)
Table 11. Global Budesonide (BUD) Sales by Application (2019-2024) & (K MT)
Table 12. Global Budesonide (BUD) Sales Market Share by Application (2019-2024)
Table 13. Global Budesonide (BUD) Revenue by Application (2019-2024)
Table 14. Global Budesonide (BUD) Revenue Market Share by Application (2019-2024)
Table 15. Global Budesonide (BUD) Sale Price by Application (2019-2024) & (USD/MT)
Table 16. Global Budesonide (BUD) Sales by Company (2019-2024) & (K MT)
Table 17. Global Budesonide (BUD) Sales Market Share by Company (2019-2024)
Table 18. Global Budesonide (BUD) Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Budesonide (BUD) Revenue Market Share by Company (2019-2024)
Table 20. Global Budesonide (BUD) Sale Price by Company (2019-2024) & (USD/MT)
Table 21. Key Manufacturers Budesonide (BUD) Producing Area Distribution and Sales Area
Table 22. Players Budesonide (BUD) Products Offered
Table 23. Budesonide (BUD) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Budesonide (BUD) Sales by Geographic Region (2019-2024) & (K MT)
Table 27. Global Budesonide (BUD) Sales Market Share Geographic Region (2019-2024)
Table 28. Global Budesonide (BUD) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Budesonide (BUD) Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Budesonide (BUD) Sales by Country/Region (2019-2024) & (K MT)
Table 31. Global Budesonide (BUD) Sales Market Share by Country/Region (2019-2024)
Table 32. Global Budesonide (BUD) Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Budesonide (BUD) Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Budesonide (BUD) Sales by Country (2019-2024) & (K MT)
Table 35. Americas Budesonide (BUD) Sales Market Share by Country (2019-2024)
Table 36. Americas Budesonide (BUD) Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Budesonide (BUD) Revenue Market Share by Country (2019-2024)
Table 38. Americas Budesonide (BUD) Sales by Type (2019-2024) & (K MT)
Table 39. Americas Budesonide (BUD) Sales by Application (2019-2024) & (K MT)
Table 40. APAC Budesonide (BUD) Sales by Region (2019-2024) & (K MT)
Table 41. APAC Budesonide (BUD) Sales Market Share by Region (2019-2024)
Table 42. APAC Budesonide (BUD) Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Budesonide (BUD) Revenue Market Share by Region (2019-2024)
Table 44. APAC Budesonide (BUD) Sales by Type (2019-2024) & (K MT)
Table 45. APAC Budesonide (BUD) Sales by Application (2019-2024) & (K MT)
Table 46. Europe Budesonide (BUD) Sales by Country (2019-2024) & (K MT)
Table 47. Europe Budesonide (BUD) Sales Market Share by Country (2019-2024)
Table 48. Europe Budesonide (BUD) Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Budesonide (BUD) Revenue Market Share by Country (2019-2024)
Table 50. Europe Budesonide (BUD) Sales by Type (2019-2024) & (K MT)
Table 51. Europe Budesonide (BUD) Sales by Application (2019-2024) & (K MT)
Table 52. Middle East & Africa Budesonide (BUD) Sales by Country (2019-2024) & (K MT)
Table 53. Middle East & Africa Budesonide (BUD) Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Budesonide (BUD) Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Budesonide (BUD) Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Budesonide (BUD) Sales by Type (2019-2024) & (K MT)
Table 57. Middle East & Africa Budesonide (BUD) Sales by Application (2019-2024) & (K MT)
Table 58. Key Market Drivers & Growth Opportunities of Budesonide (BUD)
Table 59. Key Market Challenges & Risks of Budesonide (BUD)
Table 60. Key Industry Trends of Budesonide (BUD)
Table 61. Budesonide (BUD) Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Budesonide (BUD) Distributors List
Table 64. Budesonide (BUD) Customer List
Table 65. Global Budesonide (BUD) Sales Forecast by Region (2025-2030) & (K MT)
Table 66. Global Budesonide (BUD) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Budesonide (BUD) Sales Forecast by Country (2025-2030) & (K MT)
Table 68. Americas Budesonide (BUD) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Budesonide (BUD) Sales Forecast by Region (2025-2030) & (K MT)
Table 70. APAC Budesonide (BUD) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Budesonide (BUD) Sales Forecast by Country (2025-2030) & (K MT)
Table 72. Europe Budesonide (BUD) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Budesonide (BUD) Sales Forecast by Country (2025-2030) & (K MT)
Table 74. Middle East & Africa Budesonide (BUD) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Budesonide (BUD) Sales Forecast by Type (2025-2030) & (K MT)
Table 76. Global Budesonide (BUD) Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Budesonide (BUD) Sales Forecast by Application (2025-2030) & (K MT)
Table 78. Global Budesonide (BUD) Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. AstraZeneca Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 80. AstraZeneca Budesonide (BUD) Product Portfolios and Specifications
Table 81. AstraZeneca Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. AstraZeneca Main Business
Table 83. AstraZeneca Latest Developments
Table 84. Cosmo Pharmaceuticals Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 85. Cosmo Pharmaceuticals Budesonide (BUD) Product Portfolios and Specifications
Table 86. Cosmo Pharmaceuticals Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Cosmo Pharmaceuticals Main Business
Table 88. Cosmo Pharmaceuticals Latest Developments
Table 89. Teva Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Budesonide (BUD) Product Portfolios and Specifications
Table 91. Teva Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Teva Main Business
Table 93. Teva Latest Developments
Table 94. Mylan Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 95. Mylan Budesonide (BUD) Product Portfolios and Specifications
Table 96. Mylan Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Mylan Main Business
Table 98. Mylan Latest Developments
Table 99. Sandoz Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 100. Sandoz Budesonide (BUD) Product Portfolios and Specifications
Table 101. Sandoz Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Sandoz Main Business
Table 103. Sandoz Latest Developments
Table 104. Dr. Falk Pharma Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 105. Dr. Falk Pharma Budesonide (BUD) Product Portfolios and Specifications
Table 106. Dr. Falk Pharma Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Dr. Falk Pharma Main Business
Table 108. Dr. Falk Pharma Latest Developments
Table 109. Chiesi Farmaceutici Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 110. Chiesi Farmaceutici Budesonide (BUD) Product Portfolios and Specifications
Table 111. Chiesi Farmaceutici Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Chiesi Farmaceutici Main Business
Table 113. Chiesi Farmaceutici Latest Developments
Table 114. Orion Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 115. Orion Budesonide (BUD) Product Portfolios and Specifications
Table 116. Orion Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Orion Main Business
Table 118. Orion Latest Developments
Table 119. Cipla Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 120. Cipla Budesonide (BUD) Product Portfolios and Specifications
Table 121. Cipla Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Cipla Main Business
Table 123. Cipla Latest Developments
Table 124. Synmosa Biopharma Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 125. Synmosa Biopharma Budesonide (BUD) Product Portfolios and Specifications
Table 126. Synmosa Biopharma Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Synmosa Biopharma Main Business
Table 128. Synmosa Biopharma Latest Developments
Table 129. Lunan Better Pharmaceutical Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 130. Lunan Better Pharmaceutical Budesonide (BUD) Product Portfolios and Specifications
Table 131. Lunan Better Pharmaceutical Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Lunan Better Pharmaceutical Main Business
Table 133. Lunan Better Pharmaceutical Latest Developments
Table 134. Shanghai Sine Promod Pharmaceutical Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 135. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Portfolios and Specifications
Table 136. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Shanghai Sine Promod Pharmaceutical Main Business
Table 138. Shanghai Sine Promod Pharmaceutical Latest Developments
Table 1. Budesonide (BUD) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Budesonide (BUD) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Nasal Spray
Table 4. Major Players of Inhaler
Table 5. Major Players of Pill
Table 6. Global Budesonide (BUD) Sales by Type (2019-2024) & (K MT)
Table 7. Global Budesonide (BUD) Sales Market Share by Type (2019-2024)
Table 8. Global Budesonide (BUD) Revenue by Type (2019-2024) & ($ million)
Table 9. Global Budesonide (BUD) Revenue Market Share by Type (2019-2024)
Table 10. Global Budesonide (BUD) Sale Price by Type (2019-2024) & (USD/MT)
Table 11. Global Budesonide (BUD) Sales by Application (2019-2024) & (K MT)
Table 12. Global Budesonide (BUD) Sales Market Share by Application (2019-2024)
Table 13. Global Budesonide (BUD) Revenue by Application (2019-2024)
Table 14. Global Budesonide (BUD) Revenue Market Share by Application (2019-2024)
Table 15. Global Budesonide (BUD) Sale Price by Application (2019-2024) & (USD/MT)
Table 16. Global Budesonide (BUD) Sales by Company (2019-2024) & (K MT)
Table 17. Global Budesonide (BUD) Sales Market Share by Company (2019-2024)
Table 18. Global Budesonide (BUD) Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Budesonide (BUD) Revenue Market Share by Company (2019-2024)
Table 20. Global Budesonide (BUD) Sale Price by Company (2019-2024) & (USD/MT)
Table 21. Key Manufacturers Budesonide (BUD) Producing Area Distribution and Sales Area
Table 22. Players Budesonide (BUD) Products Offered
Table 23. Budesonide (BUD) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Budesonide (BUD) Sales by Geographic Region (2019-2024) & (K MT)
Table 27. Global Budesonide (BUD) Sales Market Share Geographic Region (2019-2024)
Table 28. Global Budesonide (BUD) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Budesonide (BUD) Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Budesonide (BUD) Sales by Country/Region (2019-2024) & (K MT)
Table 31. Global Budesonide (BUD) Sales Market Share by Country/Region (2019-2024)
Table 32. Global Budesonide (BUD) Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Budesonide (BUD) Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Budesonide (BUD) Sales by Country (2019-2024) & (K MT)
Table 35. Americas Budesonide (BUD) Sales Market Share by Country (2019-2024)
Table 36. Americas Budesonide (BUD) Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Budesonide (BUD) Revenue Market Share by Country (2019-2024)
Table 38. Americas Budesonide (BUD) Sales by Type (2019-2024) & (K MT)
Table 39. Americas Budesonide (BUD) Sales by Application (2019-2024) & (K MT)
Table 40. APAC Budesonide (BUD) Sales by Region (2019-2024) & (K MT)
Table 41. APAC Budesonide (BUD) Sales Market Share by Region (2019-2024)
Table 42. APAC Budesonide (BUD) Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Budesonide (BUD) Revenue Market Share by Region (2019-2024)
Table 44. APAC Budesonide (BUD) Sales by Type (2019-2024) & (K MT)
Table 45. APAC Budesonide (BUD) Sales by Application (2019-2024) & (K MT)
Table 46. Europe Budesonide (BUD) Sales by Country (2019-2024) & (K MT)
Table 47. Europe Budesonide (BUD) Sales Market Share by Country (2019-2024)
Table 48. Europe Budesonide (BUD) Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Budesonide (BUD) Revenue Market Share by Country (2019-2024)
Table 50. Europe Budesonide (BUD) Sales by Type (2019-2024) & (K MT)
Table 51. Europe Budesonide (BUD) Sales by Application (2019-2024) & (K MT)
Table 52. Middle East & Africa Budesonide (BUD) Sales by Country (2019-2024) & (K MT)
Table 53. Middle East & Africa Budesonide (BUD) Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Budesonide (BUD) Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Budesonide (BUD) Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Budesonide (BUD) Sales by Type (2019-2024) & (K MT)
Table 57. Middle East & Africa Budesonide (BUD) Sales by Application (2019-2024) & (K MT)
Table 58. Key Market Drivers & Growth Opportunities of Budesonide (BUD)
Table 59. Key Market Challenges & Risks of Budesonide (BUD)
Table 60. Key Industry Trends of Budesonide (BUD)
Table 61. Budesonide (BUD) Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Budesonide (BUD) Distributors List
Table 64. Budesonide (BUD) Customer List
Table 65. Global Budesonide (BUD) Sales Forecast by Region (2025-2030) & (K MT)
Table 66. Global Budesonide (BUD) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Budesonide (BUD) Sales Forecast by Country (2025-2030) & (K MT)
Table 68. Americas Budesonide (BUD) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Budesonide (BUD) Sales Forecast by Region (2025-2030) & (K MT)
Table 70. APAC Budesonide (BUD) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Budesonide (BUD) Sales Forecast by Country (2025-2030) & (K MT)
Table 72. Europe Budesonide (BUD) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Budesonide (BUD) Sales Forecast by Country (2025-2030) & (K MT)
Table 74. Middle East & Africa Budesonide (BUD) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Budesonide (BUD) Sales Forecast by Type (2025-2030) & (K MT)
Table 76. Global Budesonide (BUD) Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Budesonide (BUD) Sales Forecast by Application (2025-2030) & (K MT)
Table 78. Global Budesonide (BUD) Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. AstraZeneca Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 80. AstraZeneca Budesonide (BUD) Product Portfolios and Specifications
Table 81. AstraZeneca Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. AstraZeneca Main Business
Table 83. AstraZeneca Latest Developments
Table 84. Cosmo Pharmaceuticals Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 85. Cosmo Pharmaceuticals Budesonide (BUD) Product Portfolios and Specifications
Table 86. Cosmo Pharmaceuticals Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Cosmo Pharmaceuticals Main Business
Table 88. Cosmo Pharmaceuticals Latest Developments
Table 89. Teva Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Budesonide (BUD) Product Portfolios and Specifications
Table 91. Teva Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Teva Main Business
Table 93. Teva Latest Developments
Table 94. Mylan Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 95. Mylan Budesonide (BUD) Product Portfolios and Specifications
Table 96. Mylan Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Mylan Main Business
Table 98. Mylan Latest Developments
Table 99. Sandoz Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 100. Sandoz Budesonide (BUD) Product Portfolios and Specifications
Table 101. Sandoz Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Sandoz Main Business
Table 103. Sandoz Latest Developments
Table 104. Dr. Falk Pharma Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 105. Dr. Falk Pharma Budesonide (BUD) Product Portfolios and Specifications
Table 106. Dr. Falk Pharma Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Dr. Falk Pharma Main Business
Table 108. Dr. Falk Pharma Latest Developments
Table 109. Chiesi Farmaceutici Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 110. Chiesi Farmaceutici Budesonide (BUD) Product Portfolios and Specifications
Table 111. Chiesi Farmaceutici Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Chiesi Farmaceutici Main Business
Table 113. Chiesi Farmaceutici Latest Developments
Table 114. Orion Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 115. Orion Budesonide (BUD) Product Portfolios and Specifications
Table 116. Orion Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Orion Main Business
Table 118. Orion Latest Developments
Table 119. Cipla Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 120. Cipla Budesonide (BUD) Product Portfolios and Specifications
Table 121. Cipla Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Cipla Main Business
Table 123. Cipla Latest Developments
Table 124. Synmosa Biopharma Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 125. Synmosa Biopharma Budesonide (BUD) Product Portfolios and Specifications
Table 126. Synmosa Biopharma Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Synmosa Biopharma Main Business
Table 128. Synmosa Biopharma Latest Developments
Table 129. Lunan Better Pharmaceutical Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 130. Lunan Better Pharmaceutical Budesonide (BUD) Product Portfolios and Specifications
Table 131. Lunan Better Pharmaceutical Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Lunan Better Pharmaceutical Main Business
Table 133. Lunan Better Pharmaceutical Latest Developments
Table 134. Shanghai Sine Promod Pharmaceutical Basic Information, Budesonide (BUD) Manufacturing Base, Sales Area and Its Competitors
Table 135. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Portfolios and Specifications
Table 136. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Shanghai Sine Promod Pharmaceutical Main Business
Table 138. Shanghai Sine Promod Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Budesonide (BUD)
Figure 2. Budesonide (BUD) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Budesonide (BUD) Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Budesonide (BUD) Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Budesonide (BUD) Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Nasal Spray
Figure 10. Product Picture of Inhaler
Figure 11. Product Picture of Pill
Figure 12. Global Budesonide (BUD) Sales Market Share by Type in 2023
Figure 13. Global Budesonide (BUD) Revenue Market Share by Type (2019-2024)
Figure 14. Budesonide (BUD) Consumed in Respiratory Disease Treatment
Figure 15. Global Budesonide (BUD) Market: Respiratory Disease Treatment (2019-2024) & (K MT)
Figure 16. Budesonide (BUD) Consumed in Nose Disease Treatment
Figure 17. Global Budesonide (BUD) Market: Nose Disease Treatment (2019-2024) & (K MT)
Figure 18. Budesonide (BUD) Consumed in Inflammatory Bowel Disease Treatment
Figure 19. Global Budesonide (BUD) Market: Inflammatory Bowel Disease Treatment (2019-2024) & (K MT)
Figure 20. Global Budesonide (BUD) Sales Market Share by Application (2023)
Figure 21. Global Budesonide (BUD) Revenue Market Share by Application in 2023
Figure 22. Budesonide (BUD) Sales Market by Company in 2023 (K MT)
Figure 23. Global Budesonide (BUD) Sales Market Share by Company in 2023
Figure 24. Budesonide (BUD) Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Budesonide (BUD) Revenue Market Share by Company in 2023
Figure 26. Global Budesonide (BUD) Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Budesonide (BUD) Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Budesonide (BUD) Sales 2019-2024 (K MT)
Figure 29. Americas Budesonide (BUD) Revenue 2019-2024 ($ Millions)
Figure 30. APAC Budesonide (BUD) Sales 2019-2024 (K MT)
Figure 31. APAC Budesonide (BUD) Revenue 2019-2024 ($ Millions)
Figure 32. Europe Budesonide (BUD) Sales 2019-2024 (K MT)
Figure 33. Europe Budesonide (BUD) Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Budesonide (BUD) Sales 2019-2024 (K MT)
Figure 35. Middle East & Africa Budesonide (BUD) Revenue 2019-2024 ($ Millions)
Figure 36. Americas Budesonide (BUD) Sales Market Share by Country in 2023
Figure 37. Americas Budesonide (BUD) Revenue Market Share by Country in 2023
Figure 38. Americas Budesonide (BUD) Sales Market Share by Type (2019-2024)
Figure 39. Americas Budesonide (BUD) Sales Market Share by Application (2019-2024)
Figure 40. United States Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Budesonide (BUD) Sales Market Share by Region in 2023
Figure 45. APAC Budesonide (BUD) Revenue Market Share by Regions in 2023
Figure 46. APAC Budesonide (BUD) Sales Market Share by Type (2019-2024)
Figure 47. APAC Budesonide (BUD) Sales Market Share by Application (2019-2024)
Figure 48. China Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Budesonide (BUD) Sales Market Share by Country in 2023
Figure 56. Europe Budesonide (BUD) Revenue Market Share by Country in 2023
Figure 57. Europe Budesonide (BUD) Sales Market Share by Type (2019-2024)
Figure 58. Europe Budesonide (BUD) Sales Market Share by Application (2019-2024)
Figure 59. Germany Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Budesonide (BUD) Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Budesonide (BUD) Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Budesonide (BUD) Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Budesonide (BUD) Sales Market Share by Application (2019-2024)
Figure 68. Egypt Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Budesonide (BUD) in 2023
Figure 74. Manufacturing Process Analysis of Budesonide (BUD)
Figure 75. Industry Chain Structure of Budesonide (BUD)
Figure 76. Channels of Distribution
Figure 77. Global Budesonide (BUD) Sales Market Forecast by Region (2025-2030)
Figure 78. Global Budesonide (BUD) Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Budesonide (BUD) Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Budesonide (BUD) Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Budesonide (BUD) Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Budesonide (BUD) Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Budesonide (BUD)
Figure 2. Budesonide (BUD) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Budesonide (BUD) Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Budesonide (BUD) Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Budesonide (BUD) Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Nasal Spray
Figure 10. Product Picture of Inhaler
Figure 11. Product Picture of Pill
Figure 12. Global Budesonide (BUD) Sales Market Share by Type in 2023
Figure 13. Global Budesonide (BUD) Revenue Market Share by Type (2019-2024)
Figure 14. Budesonide (BUD) Consumed in Respiratory Disease Treatment
Figure 15. Global Budesonide (BUD) Market: Respiratory Disease Treatment (2019-2024) & (K MT)
Figure 16. Budesonide (BUD) Consumed in Nose Disease Treatment
Figure 17. Global Budesonide (BUD) Market: Nose Disease Treatment (2019-2024) & (K MT)
Figure 18. Budesonide (BUD) Consumed in Inflammatory Bowel Disease Treatment
Figure 19. Global Budesonide (BUD) Market: Inflammatory Bowel Disease Treatment (2019-2024) & (K MT)
Figure 20. Global Budesonide (BUD) Sales Market Share by Application (2023)
Figure 21. Global Budesonide (BUD) Revenue Market Share by Application in 2023
Figure 22. Budesonide (BUD) Sales Market by Company in 2023 (K MT)
Figure 23. Global Budesonide (BUD) Sales Market Share by Company in 2023
Figure 24. Budesonide (BUD) Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Budesonide (BUD) Revenue Market Share by Company in 2023
Figure 26. Global Budesonide (BUD) Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Budesonide (BUD) Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Budesonide (BUD) Sales 2019-2024 (K MT)
Figure 29. Americas Budesonide (BUD) Revenue 2019-2024 ($ Millions)
Figure 30. APAC Budesonide (BUD) Sales 2019-2024 (K MT)
Figure 31. APAC Budesonide (BUD) Revenue 2019-2024 ($ Millions)
Figure 32. Europe Budesonide (BUD) Sales 2019-2024 (K MT)
Figure 33. Europe Budesonide (BUD) Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Budesonide (BUD) Sales 2019-2024 (K MT)
Figure 35. Middle East & Africa Budesonide (BUD) Revenue 2019-2024 ($ Millions)
Figure 36. Americas Budesonide (BUD) Sales Market Share by Country in 2023
Figure 37. Americas Budesonide (BUD) Revenue Market Share by Country in 2023
Figure 38. Americas Budesonide (BUD) Sales Market Share by Type (2019-2024)
Figure 39. Americas Budesonide (BUD) Sales Market Share by Application (2019-2024)
Figure 40. United States Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Budesonide (BUD) Sales Market Share by Region in 2023
Figure 45. APAC Budesonide (BUD) Revenue Market Share by Regions in 2023
Figure 46. APAC Budesonide (BUD) Sales Market Share by Type (2019-2024)
Figure 47. APAC Budesonide (BUD) Sales Market Share by Application (2019-2024)
Figure 48. China Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Budesonide (BUD) Sales Market Share by Country in 2023
Figure 56. Europe Budesonide (BUD) Revenue Market Share by Country in 2023
Figure 57. Europe Budesonide (BUD) Sales Market Share by Type (2019-2024)
Figure 58. Europe Budesonide (BUD) Sales Market Share by Application (2019-2024)
Figure 59. Germany Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Budesonide (BUD) Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Budesonide (BUD) Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Budesonide (BUD) Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Budesonide (BUD) Sales Market Share by Application (2019-2024)
Figure 68. Egypt Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Budesonide (BUD) Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Budesonide (BUD) in 2023
Figure 74. Manufacturing Process Analysis of Budesonide (BUD)
Figure 75. Industry Chain Structure of Budesonide (BUD)
Figure 76. Channels of Distribution
Figure 77. Global Budesonide (BUD) Sales Market Forecast by Region (2025-2030)
Figure 78. Global Budesonide (BUD) Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Budesonide (BUD) Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Budesonide (BUD) Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Budesonide (BUD) Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Budesonide (BUD) Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Cannabinoid-based Antitumor Drug Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
85 pages
Global Intra Oral Scanners For Digital Impression Market Growth 2025-2031
US$ 3,660.00
May 2025
116 pages
Global Medical Protective Glasses Market Growth 2023-2029
US$ 3,660.00
March 2023
100 pages
Global Dental Consumables and Dental Instruments Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
159 pages
Global Medical Electronic Thermometer Market Growth 2025-2031
US$ 3,660.00
April 2025
182 pages
